• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 IL-2、IL-15 和 IL-18 的联合使用,从外周血中高效生成具有更好细胞活力和增强细胞毒性的自然杀伤细胞。

High-efficient generation of natural killer cells from peripheral blood with preferable cell vitality and enhanced cytotoxicity by combination of IL-2, IL-15 and IL-18.

机构信息

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.

Institute of Stem Cells, Beijing Health-Biotech Biotechnology Co. Ltd, Beijing, 100176, China.

出版信息

Biochem Biophys Res Commun. 2021 Jan 1;534:149-156. doi: 10.1016/j.bbrc.2020.12.012. Epub 2020 Dec 11.

DOI:10.1016/j.bbrc.2020.12.012
PMID:33309274
Abstract

Natural killer (NK) cells are pivotal effector lymphocytes characterized for the innate immune response to pathogenic microorganism and tumor cells without priming and sensitization. Despite emerging knowledge has highlighted the rosy prospects in tumor immunosurveillance, yet the large-scale clinical application of NK cell-based therapy is hindered largely attributes to the defects in generating sufficient and high-quality cellular products. Herein, on the basis of 16 kinds of candidate combinations, we investigated the feasibility of cytokine cocktail-based strategy for convenient and standardized NK cell cultivation as well as the multifaceted characteristics and cytotoxicity against tumor cells. Our results revealed that joint utilization of Interleukin (IL)-2, IL-15, IL-18 manifested the optimal facilitation upon the ex vivo expansion and proportion of NK cells in peripheral blood mononuclear cells (PBMCs). Meanwhile, the obtained NK cell population expressed high levels of activating molecules (CD16 and NKG2D) and exhibited splendid cytotoxicity against K562 cell line. Collectively, with the aid of cytokine-based programming, we established an alternative strategy for facilitating the large-scale persistence and activation of NK cells from peripheral blood, which would benefit the NK cell- and chimeric antigen receptor-modified NK (CAR-NK) cell-based autologous or allogeneic tumor immunotherapy.

摘要

自然杀伤 (NK) 细胞是先天免疫反应的关键效应淋巴细胞,能够识别病原体微生物和肿瘤细胞,而无需预先致敏。尽管新的研究进展强调了肿瘤免疫监视的广阔前景,但 NK 细胞为基础的治疗的大规模临床应用在很大程度上受到产生足够数量和高质量细胞产品的缺陷的阻碍。在此基础上,我们在 16 种候选组合的基础上,研究了基于细胞因子鸡尾酒的策略在方便和标准化 NK 细胞培养方面的可行性,以及对肿瘤细胞的多方面特性和细胞毒性。我们的结果表明,白细胞介素 (IL)-2、IL-15 和 IL-18 的联合使用对体外扩增和外周血单个核细胞 (PBMCs) 中 NK 细胞的比例具有最佳的促进作用。同时,获得的 NK 细胞群体表达高水平的激活分子 (CD16 和 NKG2D),并对 K562 细胞系表现出极好的细胞毒性。总之,通过基于细胞因子的编程,我们建立了一种促进外周血 NK 细胞大规模持久和激活的替代策略,这将有利于 NK 细胞和嵌合抗原受体修饰的 NK (CAR-NK) 细胞的自体或同种异体肿瘤免疫治疗。

相似文献

1
High-efficient generation of natural killer cells from peripheral blood with preferable cell vitality and enhanced cytotoxicity by combination of IL-2, IL-15 and IL-18.通过 IL-2、IL-15 和 IL-18 的联合使用,从外周血中高效生成具有更好细胞活力和增强细胞毒性的自然杀伤细胞。
Biochem Biophys Res Commun. 2021 Jan 1;534:149-156. doi: 10.1016/j.bbrc.2020.12.012. Epub 2020 Dec 11.
2
Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.人自然杀伤细胞制备的优化:全自动分离,使用 IL-21 和自体饲养细胞进行体外扩增的改进,以及生成表达抗 CD123-CAR 的效应细胞。
Hum Gene Ther. 2017 Oct;28(10):897-913. doi: 10.1089/hum.2017.157. Epub 2017 Aug 15.
3
Human IL-15 Inhibits NK Cells Specific for Human NK-92 Cells.人白细胞介素 15 抑制针对人 NK-92 细胞的 NK 细胞。
Anticancer Res. 2021 Jul;41(7):3281-3285. doi: 10.21873/anticanres.15114.
4
Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.细胞因子诱导的记忆样自然杀伤细胞具有增强的功能、增殖能力,并在体内扩增以对抗卵巢癌细胞。
Gynecol Oncol. 2019 Apr;153(1):149-157. doi: 10.1016/j.ygyno.2019.01.006. Epub 2019 Jan 15.
5
Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.白细胞介素-18与白细胞介素-2在人自然杀伤细胞的细胞毒性和NKG2D表达中的协同作用。
Asian Pac J Cancer Prev. 2014;15(18):7857-61. doi: 10.7314/apjcp.2014.15.18.7857.
6
Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.重组白细胞介素-15增强HIV感染患者外周血单个核细胞的自然杀伤及抗体依赖性细胞溶解活性
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 1;16(3):137-45. doi: 10.1097/00042560-199711010-00001.
7
IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation.IL-18/IL-15/IL-12协同作用可诱导体外扩增的自然杀伤细胞产生升高且持续时间延长的干扰素-γ,这并非由于STAT4激活增强所致。
Mol Immunol. 2017 Aug;88:138-147. doi: 10.1016/j.molimm.2017.06.025. Epub 2017 Jun 20.
8
Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.用白细胞介素-2、白细胞介素-15或白细胞介素-12与白细胞介素-18组合培养获得的NK/T-NK细胞的细胞因子产生及杀伤活性。
J Immunol. 2000 Aug 15;165(4):1847-53. doi: 10.4049/jimmunol.165.4.1847.
9
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion.白细胞介素-2(IL-2)对 NK 细胞受体的调控作用与 CD16+和 CD16-亚群的分布有关,以及同种异体 NK 细胞输注后的体内影响。
J Immunother. 2010 Feb-Mar;33(2):200-10. doi: 10.1097/CJI.0b013e3181bb46f7.
10
The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors.促炎细胞因子白细胞介素-2(IL-2)、白细胞介素-15(IL-15)和白细胞介素-21(IL-21)可调节成熟人类自然杀伤细胞受体库。
Arthritis Res Ther. 2007;9(6):R125. doi: 10.1186/ar2336.

引用本文的文献

1
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances.自然杀伤细胞在癌症免疫治疗中的作用:机制、逃逸策略及治疗进展
Biomedicines. 2025 Apr 2;13(4):857. doi: 10.3390/biomedicines13040857.
2
Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy.解锁CAR-NK细胞疗法现有瓶颈的新型基因操作方法。
Front Cell Dev Biol. 2025 Feb 11;12:1511931. doi: 10.3389/fcell.2024.1511931. eCollection 2024.
3
Clinical value of CD3CD56 natural killer cells, IL-2, and IL-8 in acute exacerbation of chronic obstructive pulmonary disease in patients with respiratory failure.
CD3CD56自然杀伤细胞、白细胞介素-2和白细胞介素-8在慢性阻塞性肺疾病急性加重期合并呼吸衰竭患者中的临床价值
Am J Transl Res. 2024 Nov 15;16(11):6477-6488. doi: 10.62347/TYUO6357. eCollection 2024.
4
Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023.嵌合抗原受体自然杀伤 (CAR-NK) 细胞免疫疗法:2004 年至 2023 年的文献计量分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2415187. doi: 10.1080/21645515.2024.2415187. Epub 2024 Oct 16.
5
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial.异基因CD5特异性嵌合抗原受体T细胞疗法治疗复发/难治性T细胞急性淋巴细胞白血病:一项1期试验。
Nat Med. 2025 Jan;31(1):126-136. doi: 10.1038/s41591-024-03282-2. Epub 2024 Oct 1.
6
CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges.嵌合抗原受体自然杀伤细胞疗法:克服肿瘤学挑战的变革性方法。
Biomolecules. 2024 Aug 20;14(8):1035. doi: 10.3390/biom14081035.
7
Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions.嵌合抗原受体自然杀伤细胞(CAR-NK)疗法在肿瘤免疫治疗中的新兴作用:现状与未来方向。
Cell Death Discov. 2024 Jul 10;10(1):318. doi: 10.1038/s41420-024-02077-1.
8
Feeder-free differentiation of human iPSCs into natural killer cells with cytotoxic potential against malignant brain rhabdoid tumor cells.将人诱导多能干细胞无饲养层分化为对恶性脑横纹肌样瘤细胞具有细胞毒性潜力的自然杀伤细胞。
Bioact Mater. 2024 Mar 8;36:301-316. doi: 10.1016/j.bioactmat.2024.02.031. eCollection 2024 Jun.
9
Uncovering the cellular and omics characteristics of natural killer cells in the bone marrow microenvironment of patients with acute myeloid leukemia.揭示急性髓系白血病患者骨髓微环境中自然杀伤细胞的细胞和组学特征。
Cancer Cell Int. 2024 Mar 14;24(1):106. doi: 10.1186/s12935-024-03300-w.
10
Development of NK cell-based cancer immunotherapies through receptor engineering.通过受体工程开发基于自然杀伤细胞的癌症免疫疗法。
Cell Mol Immunol. 2024 Apr;21(4):315-331. doi: 10.1038/s41423-024-01145-x. Epub 2024 Mar 5.